Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute USD Opportunity Assessment & Y-o-Y Analysis, 2022-2035
2.3 Market Size & Forecast, By Segmentation, 2022-2035
2.3.1 Market Size By Product Type
2.3.2 Market Size By Access Type
2.3.3 Market Size By Procedure
2.3.4 Market Size By End-User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Product Type & Device Technology Metrics
4.1.1 Passive closure devices vs active closure systems adoption trends
4.1.2 Collagen-based vascular closure device utilization metrics
4.1.3 Suture-mediated closure system performance trends
4.1.4 Clip-based and sealant-based device adoption dynamics
4.1.5 Percutaneous closure device innovation and usage metrics
4.1.6 Femoral artery vs radial artery closure device utilization
4.1.7 Next-generation bioresorbable closure technology development
4.2 Clinical Application Metrics
4.2.1 Cardiology catheterization procedure closure demand trends
4.2.2 Interventional radiology procedure closure adoption metrics
4.2.3 Peripheral vascular intervention closure performance trends
4.2.4 Endovascular aneurysm repair (EVAR) closure utilization
4.2.5 Neurovascular intervention closure device adoption metrics
4.2.6 Electrophysiology and cardiac ablation closure usage trends
4.2.7 Ambulatory surgical center vascular closure demand growth
4.3 Procedural Efficiency & Clinical Outcomes Metrics
4.3.1 Hemostasis achievement time reduction performance
4.3.2 Patient ambulation time and early mobility improvement metrics
4.3.3 Access site complication rate reduction trends
4.3.4 Hematoma and bleeding risk mitigation performance
4.3.5 Procedural success rate and device reliability metrics
4.3.6 Post-procedure hospitalization duration reduction trends
4.3.7 Overall clinical outcome improvement in vascular intervention
5. Vascular Closure Devices Market Segmental Analysis & Forecast, By Product Type, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 Passive Approximators
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Active Approximators
6. Vascular Closure Devices Market Segmental Analysis & Forecast, By Access Type, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Femoral
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Radial
6.4 Others
7. Vascular Closure Devices Market Segmental Analysis & Forecast, By Procedure, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Interventional Cardiology
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Interventional Radiology
7.4 Endovascular Surgery
8. Vascular Closure Devices Market Segmental Analysis & Forecast, By End-User, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Ambulatory Surgical Centers
8.4 Others
9. Vascular Closure Devices Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Vascular Closure Devices Market Size & Forecast, By Product Type, 2022 – 2035
9.2.3 Vascular Closure Devices Market Size & Forecast, By Access Type, 2022 – 2035
9.2.4 Vascular Closure Devices Market Size & Forecast, By Procedure, 2022 – 2035
9.2.5 Vascular Closure Devices Market Size & Forecast, By End-User, 2022 – 2035
9.2.6 Vascular Closure Devices Market Size & Forecast, By Country, 2022 – 2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Vascular Closure Devices Market Size & Forecast, By Product Type, 2022 – 2035
9.3.3 Vascular Closure Devices Market Size & Forecast, By Access Type, 2022 – 2035
9.3.4 Vascular Closure Devices Market Size & Forecast, By Procedure, 2022 – 2035
9.3.5 Vascular Closure Devices Market Size & Forecast, By End-User, 2022 – 2035
9.3.6 Vascular Closure Devices Market Size & Forecast, By Country, 2022 – 2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Vascular Closure Devices Market Size & Forecast, By Product Type, 2022 – 2035
9.4.3 Vascular Closure Devices Market Size & Forecast, By Access Type, 2022 – 2035
9.4.4 Vascular Closure Devices Market Size & Forecast, By Procedure, 2022 – 2035
9.4.5 Vascular Closure Devices Market Size & Forecast, By End-User, 2022 – 2035
9.4.6 Vascular Closure Devices Market Size & Forecast, By Country, 2022 – 2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Vascular Closure Devices Market Size & Forecast, By Product Type, 2022 – 2035
9.5.3 Vascular Closure Devices Market Size & Forecast, By Access Type, 2022 – 2035
9.5.4 Vascular Closure Devices Market Size & Forecast, By Procedure, 2022 – 2035
9.5.5 Vascular Closure Devices Market Size & Forecast, By End-User, 2022 – 2035
9.5.6 Vascular Closure Devices Market Size & Forecast, By Country, 2022 – 2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Vascular Closure Devices Market Size & Forecast, By Product Type, 2022 – 2035
9.6.3 Vascular Closure Devices Market Size & Forecast, By Access Type, 2022 – 2035
9.6.4 Vascular Closure Devices Market Size & Forecast, By Procedure, 2022 – 2035
9.6.5 Vascular Closure Devices Market Size & Forecast, By End-User, 2022 – 2035
9.6.6 Vascular Closure Devices Market Size & Forecast, By Country, 2022 – 2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Abbott Laboratories
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Teleflex Incorporated
10.6.3 Haemonetics Corporation
10.6.4 Terumo Corporation
10.6.5 Medtronic plc
10.6.6 Boston Scientific Corporation
10.6.7 Cardinal Health Inc.
10.6.8 Becton, Dickinson and Company (BD)
10.6.9 B. Braun Melsungen AG
10.6.10 Johnson & Johnson MedTech
10.6.11 Cordis (Cardinal Health)
10.6.12 Vasorum Ltd.
10.6.13 INVAMED
10.6.14 Vivasure Medical Ltd.
10.6.15 Merit Medical Systems Inc.
10.6.16 Vascular Solutions (Teleflex)
10.6.17 TZ Medical Inc.
10.6.18 Transluminal Technologies LLC
10.6.19 InVivo Therapeutics Holdings Corp.
10.6.20 Tricol Biomedical Inc.
11. Analyst Recommendation
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figure
Frequently Asked Questions
North America dominated the Vascular Closure Devices Market in 2025 with approximately 42.67% of global revenues, led by the United States the world's highest-volume interventional cardiovascular procedure market supported by the most favourable VCD reimbursement policies, rapid structural heart programme expansion, and the commercial presence of leading VCD innovators including Abbott, Medtronic, Teleflex, and Haemonetics.
Active Approximators encompassing suture-mediated and clip-based closure systems dominated the market in 2025 with approximately 54% of global revenue, driven by their superior hemostasis reliability, broad clinical applicability across arterial access sizes, and extensive procedural adoption in PCI, TAVR, and peripheral vascular interventions.
Rising global interventional cardiovascular procedure volumes driven by escalating CVD burden, the rapid expansion of structural heart interventions including TAVR and LAAC creating premium large-bore VCD demand, and the clinical and economic superiority of device-based closure over manual compression enabling same-day discharge protocols are the primary structural growth drivers through 2035.
The Vascular Closure Devices Market was valued at USD 1.92 billion in 2025.
The Vascular Closure Devices Market is expected to grow at a CAGR of 7.85% from 2026 to 2035.
Get in Touch
